KR910017189A - Cancer Diagnosis and Kits Used Thereof - Google Patents

Cancer Diagnosis and Kits Used Thereof Download PDF

Info

Publication number
KR910017189A
KR910017189A KR1019910003819A KR910003819A KR910017189A KR 910017189 A KR910017189 A KR 910017189A KR 1019910003819 A KR1019910003819 A KR 1019910003819A KR 910003819 A KR910003819 A KR 910003819A KR 910017189 A KR910017189 A KR 910017189A
Authority
KR
South Korea
Prior art keywords
serodiagnostic
chitochrome
serum
cancer diagnosis
antibody
Prior art date
Application number
KR1019910003819A
Other languages
Korean (ko)
Inventor
슈이찌 하시즈메
마사또시 가또
마사노리 가메이
Original Assignee
마쯔자끼 아끼오
모리나가 세이까 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5723690A external-priority patent/JPH03257367A/en
Priority claimed from JP13914690A external-priority patent/JPH0432766A/en
Application filed by 마쯔자끼 아끼오, 모리나가 세이까 가부시끼가이샤 filed Critical 마쯔자끼 아끼오
Publication of KR910017189A publication Critical patent/KR910017189A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/80—Cytochromes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음No content

Description

암의 혈청진단법 및 이에 사용되는 키트(kit)Cancer Diagnosis and Kits Used Thereof

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (9)

치토크롬 c를 사용하는 것을 포함하는, 암을 검출하기 위한 혈청진단법.A serodiagnostic method for detecting cancer, comprising using chitochrome c. 제1항에 있어서, 칸디다(Candida) 및 효모를 포함하는 미생물로 부터 치토크롬 c를 유도하는 혈청진단법.The method of claim 1, wherein the serum diagnostic method for inducing chitochrome c from microorganisms, including Candida and yeast. 제1항 또는 제2항에 있어서, 혈액중에서 치토크롬 c와 반응하는 항체를 측정하는 혈청진단법.The serodiagnostic method according to claim 1 or 2, wherein the antibody is measured for reacting with chitochrome c in blood. 제1항 내지 제3항중 어느 하나에 있어서, 효소-라벨된 항체를 사용하는 혈청진단법.The serodiagnosis method according to any one of claims 1 to 3, using an enzyme-labeled antibody. 히스톤을 사용하는 것을 포함하는, 암을 검출하기 위한 혈청진단법.Serum diagnostics for detecting cancer, comprising using histones. 제5항에 있어서, 히스톤이 H1, H2A, H2B, H3 및 H4 중 하나인 혈청진단법.6. The serodiagnostic method according to claim 5, wherein the histone is one of H1, H2A, H2B, H3 and H4. 제5항 내지 제6항에 있어서, 혈액중에 히스톤과 반응하는 항체를 측정하는 혈청진단법.The serodiagnostic method according to claim 5, wherein the antibody is measured for reacting with histones in blood. 제5항 내지 제7항중 어느 하나에 있어서, 효소-라벨된 항체를 사용하는 혈청진단법.The serum diagnostic method according to any one of claims 5 to 7, wherein the enzyme-labeled antibody is used. 제1항 내지 제8항중 어느 하나에 따른 혈청진단법을 이용하기 위한 혈청진단 키트.A serum diagnostic kit for using the serum diagnostic method according to any one of claims 1 to 8. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019910003819A 1990-03-08 1991-03-07 Cancer Diagnosis and Kits Used Thereof KR910017189A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5723690A JPH03257367A (en) 1990-03-08 1990-03-08 Serodiagnosis
JP57236/90 1990-03-08
JP139146/90 1990-05-29
JP13914690A JPH0432766A (en) 1990-05-29 1990-05-29 Serum diagnostic method

Publications (1)

Publication Number Publication Date
KR910017189A true KR910017189A (en) 1991-11-05

Family

ID=26398252

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910003819A KR910017189A (en) 1990-03-08 1991-03-07 Cancer Diagnosis and Kits Used Thereof

Country Status (4)

Country Link
KR (1) KR910017189A (en)
DE (1) DE4107334A1 (en)
FR (1) FR2659449A1 (en)
GB (1) GB2241782B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807999A (en) * 1993-02-01 1998-09-15 Mt. Sinai School Of Medicine Of The City University Of New York Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 and uses therefor
ES2288877T3 (en) * 1999-11-08 2008-02-01 EISAI R&D MANAGEMENT CO., LTD. METHOD AND REAGENT TO DETECT CELL DEATH.
US7138239B2 (en) 2001-05-09 2006-11-21 Eisai Co., Ltd. Method and reagent for testing for multiple organ failure in SIRS by cytochrome C measurement
EP1501869A4 (en) * 2001-08-03 2006-01-11 Univ Virginia Phosphorylated histone h2b as an apoptosis marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906819A (en) * 1958-04-28 1962-09-26 Masaka Matsubara Parenteral solution for diagnostic test of cancer and a process of preparing same
DE3737274A1 (en) * 1987-11-03 1989-06-01 Rusch Volker Use of pure H2A and/or H2B histone as active substance for the production of pharmaceutical compositions
AU2800389A (en) * 1987-12-02 1989-07-05 Regents Of The University Of California, The Aids-related anti-t-cell antibody test
JP2675117B2 (en) * 1988-05-13 1997-11-12 森永製菓株式会社 Serum measurement method of cancer

Also Published As

Publication number Publication date
GB2241782B (en) 1993-12-08
FR2659449A1 (en) 1991-09-13
GB9104915D0 (en) 1991-04-24
GB2241782A (en) 1991-09-11
DE4107334A1 (en) 1991-09-12

Similar Documents

Publication Publication Date Title
LV10538A (en) Influence of immunologically binding agent on biological fluid and diagnostic agent
KR890702038A (en) Enzyme Immunoassay for Detection of HIV Antigen in Human Serum
KR830010384A (en) Method for measuring antigen antibody response and its reagent
NO864709L (en) GRAMNEGATIVE BACTERIURI DISPLAY.
EP0279097A3 (en) Immunoassay test strip
KR890702039A (en) How to Analyze 1,25-Dihydroxy Vitamin D
ES512498A0 (en) "METHOD AND ITS CORRESPONDING DEVICE FOR THE TESTING OF ANTIBODIES WITH RESPECT TO SOLUBLE ANTIGENS".
KR950032639A (en) Assays to Measure Proteins in Biological Samples
NO874140D0 (en) IMMUNOMETRIC DETERMINATION PROCEDURES.
KR870007426A (en) Monoclonal Antibodies and Methods for Measuring Glucoxylated Proteins Using the Same
KR930703612A (en) Methods of Detecting Anti-RNA Antibodies
KR910017189A (en) Cancer Diagnosis and Kits Used Thereof
KR900004935A (en) Lipoprotein I (OMPI), Pseudomonas aeruginosa
KR920017670A (en) Monoclonal antibodies
KR890008313A (en) Anti PCI monoclonal antibody
ES2076221T3 (en) GEMINAL DERIVATIVES OF DIFENYL AND ITS USE IN IMMUNO ASSAYS.
KR900017549A (en) Cancer Serum Diagnosis
KR950009257A (en) Osteoporosis Diagnostics
CA2123069A1 (en) Immunoassay for analytes in samples using alkylating agents
DE69533904D1 (en) Chemical modification of antibodies and antigens
KR850700158A (en) Methods for Detecting Malignant Proliferation
ES2056132T3 (en) IMMUNOCHEMICAL TEST AGENT CONTAINING AMINE OXIDES.
KR860007545A (en) Method for quantifying human prolyl 4-hydroxylase
KR910001378A (en) HIV p24 quantification panel
KR850003169A (en) Measurement method and reagent of basic fetal protein

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application